Cargando…
COVID-19: a potential driver of immune-mediated breast cancer recurrence?
Severe coronavirus disease 2019 (COVID-19) causes a hyperactivation of immune cells, resulting in lung inflammation. Recent studies showed that COVID-19 induces the production of factors previously implicated in the reawakening of dormant breast cancer cells such as neutrophil extracellular traps (N...
Autores principales: | Francescangeli, Federica, De Angelis, Maria Laura, Zeuner, Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598231/ https://www.ncbi.nlm.nih.gov/pubmed/33126915 http://dx.doi.org/10.1186/s13058-020-01360-0 |
Ejemplares similares
-
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
por: De Angelis, Maria Laura, et al.
Publicado: (2019) -
Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19
por: De Angelis, Maria Laura, et al.
Publicado: (2021) -
Dietary Factors in the Control of Gut Homeostasis, Intestinal Stem Cells, and Colorectal Cancer
por: Francescangeli, Federica, et al.
Publicado: (2019) -
COVID-19–Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?
por: Francescangeli, Federica, et al.
Publicado: (2020) -
Colorectal Cancer Stem Cells: An Overview of Evolving Methods and Concepts
por: De Angelis, Maria Laura, et al.
Publicado: (2021)